Hyaluronic acid in the treatment of dry eye disease.

"For the sake of transparency, Tor Paaske Utheim is co‐founder and co‐owner of The Norwegian dry eye clinic and the Clinic of eye health, Oslo, Norway, which delivers talks for and/or receives financial support from: ABIGO, Alcon, Allergan, AMWO, Bausch&Lomb, Bayer, European school for advanced studies in ophthalmology, InnZ Medical, Medilens Nordic, Medistim, Novartis, Santen, Specsavers, Shire Pharmaceuticals and Thea Laboratories. He has served on the global scientific advisory board for Novartis and Alcon, and on the European advisory board for Shire Pharmaceuticals. Utheim is the Norwegian Global Ambassador for the Tear Film and Ocular Surface Society (TFOS), a Board Member of the International Ocular Surface Society, an international member of the Japanese Lid and Meibomian gland working group (LIME), a Consultant at the Norwegian Association for the Blind and Partially Sighted, the President of the Oslo Society of ophthalmology, and the Editor‐in‐Chief of the eye journal Oftalmolog which contains advertisements from pharmaceutical companies, companies selling ophthalmological equipment, and associations organizing conferences and events in ophthalmology."

"Darlene Dartt is supported by US NIH grants R01EY019470 and R01EY029789."